Report reveals 70% of medtechs use manual processes for managing content and claims

Reducing content approvals from more than four weeks and automating claims are key opportunities to drive speed to market pleasanton, calif. , nov. 21, 2024 /prnewswire/ -- veeva systems (nyse: veev) today announced findings from the 2024 veeva medtech commercial benchmark survey revealing nearly 70% of medtech organizations rely on manual processes and homegrown applications to manage commercial content and claims.
VEEV Ratings Summary
VEEV Quant Ranking